Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients
Status:
Withdrawn
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
A randomized phase II study comparing the sequential use of abiraterone followed after
progression by apalutamide with alternating cycles of abiraterone and apalutamide